Tag: CBT > Cannabis DEA: Page 2

Cannabis Rescheduling

Interlocutory Appeal Could Derail Cannabis Rescheduling Hearing

New evidence prompted rescheduling advocates’ second effort to oust the DEA from the hearing; if relief is denied, they will seek the appeal.

January 8, 2025

Industry Headlines

Attorney General, DEA Director, Judge Under Federal Court Summons Over DEA Marijuana Policy

Despite the DEA’s policy, MMJ International is moving forward with the FDA on cannabis drug development for Huntington’s disease.

January 6, 2025

Top Stories

Judge Calls DEA Subpoena Request ‘Blunder,’ Rejects 3 of 4 for Cannabis Rescheduling Hearing

Administrative Law Judge John Mulrooney points out the DEA’s error yet provides the agency another shot at subpoenaing three FDA officials.

December 17, 2024

Industry Headlines

Cannabis Bioscience Fights to Include Longtime Patient as Witness in DEA Rescheduling Hearing

As a designated participant, the company filed a petition to allow testimony from Alexis Bortell, who was diagnosed with intractable epilepsy as a child.

December 16, 2024

Industry Headlines

DEA Continues to Block MMJ Marijuana Drug Development for Neurological Disorder

MMJ submitted an FDA Investigational New Drug application for a cannabis-derived medication.

December 11, 2024

Top Stories

Attorney General Undelegated DEA’s Rescheduling Authority, Lawyers Argue; Possible Stay Could Delay Hearings

The cannabis rescheduling buck stops with the DOJ head, according to attorneys arguing that the DEA administrator cannot issue the final rule.

December 5, 2024

Top Stories

DEA Counsel Dodges Question on Support for Cannabis Rescheduling

An administrative law judge asked the agency’s lead attorney the question during preliminary proceedings for an upcoming rescheduling hearing.

December 2, 2024

Top Stories

DEA Could Subpoena HHS in Cannabis Rescheduling Hearings

The Drug Enforcement Administration indicated it could target a ‘novel’ two-factor test used to determine currently accepted medical use.

November 26, 2024

Top Stories

Smart Approaches to Marijuana Responds to Claims It Colluded With DEA

The prohibitionist group says cannabis rescheduling advocates are attempting to ‘create a sideshow’ of the DEA’s hearing process.

November 25, 2024

Top Stories

DEA Denies Collusion Allegations Ahead of Cannabis Rescheduling Hearing

The DEA argues that cannabis advocates have no evidence that the agency engaged in unlawful communications with a prohibitionist group.

November 25, 2024

Top Stories

2 US House Democrats Nudge DEA to ‘Swiftly’ Reschedule Cannabis

Reps. Jerry Nadler and Frank Pallone Jr., both ranking members, wrote a letter to the attorney general and DEA administrator.

October 2, 2024

Cannabis Industry Research

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

September 20, 2024